Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress Read more about Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress Synlogic to Present at Upcoming Investor Conferences in November Read more about Synlogic to Present at Upcoming Investor Conferences in November Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia Read more about Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic BioticTM Medicine for the Treatment of Phenylketonuria Read more about Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic BioticTM Medicine for the Treatment of Phenylketonuria Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer Read more about Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer Synlogic to Webcast Presentation at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology Read more about Synlogic to Webcast Presentation at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology Joseph Schwartz Joseph Schwartz SVBLeerink Joe.Schwartz@svbleerink.com Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism Read more about Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference Read more about Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference Synlogic Completes Merger with Mirna Therapeutics Read more about Synlogic Completes Merger with Mirna Therapeutics Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress Read more about Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress
Synlogic to Present at Upcoming Investor Conferences in November Read more about Synlogic to Present at Upcoming Investor Conferences in November
Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia Read more about Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia
Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic BioticTM Medicine for the Treatment of Phenylketonuria Read more about Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic BioticTM Medicine for the Treatment of Phenylketonuria
Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer Read more about Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer
Synlogic to Webcast Presentation at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology Read more about Synlogic to Webcast Presentation at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism Read more about Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism
Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference Read more about Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference
Synlogic Completes Merger with Mirna Therapeutics Read more about Synlogic Completes Merger with Mirna Therapeutics